Quince Therapeutics, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the Annual Meeting of Stockholders held on June 11, 2026. Quince Therapeutics, Inc. (QNCX), a Delaware corporation, conducted the meeting via live webcast. Approximately 38.37% of total outstanding shares eligible to be voted were present or represented by proxy.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
Stockholders approved five key proposals at the Annual Meeting:
- Election of Directors: June Bray was elected as a Class I director to serve until the 2029 annual meeting. She received 2,430,964 votes for, with 216,735 votes withheld and 3,607,640 broker non-votes.
- Reverse Stock Split: Stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio ranging from 1-for-10 to 1-for-100. The Board retains sole discretion on the timing and specific ratio. The vote was 4,715,574 for, 1,517,896 against, and 21,866 abstentions.
- Accounting Firm Ratification: BDO USA, P.C. was ratified as the independent registered accounting firm for the fiscal year ending December 31, 2026. The vote was 6,080,608 for, 111,522 against, and 63,207 abstentions.
- Executive Compensation: Stockholders approved, on an advisory basis, the compensation of named executive officers. The vote was 2,504,778 for, 116,876 against, and 26,044 abstentions.
- Adjournment: Stockholders approved the ability to adjourn or postpone the meeting to solicit further proxies. The vote was 5,236,032 for, 987,376 against, and 31,929 abstentions.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary on future operations, or a discussion of risks and contingencies beyond the standard voting results. The approval of the reverse stock split suggests a strategic move to potentially improve share price or meet listing requirements, though the specific ratio and timing remain at the Board's discretion.
Investor Verification Checklist
- Verify the specific reverse stock split ratio and effective date once determined by the Board of Directors.
- Confirm the impact of the reverse stock split on the number of shares held and the adjusted share price.
- Review the full proxy statement for details on the executive compensation package that was approved.
- Monitor future filings for the official implementation of the Certificate of Incorporation amendment.